Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hockings, J. K.
Right arrow Articles by Romagnolo, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hockings, J. K.
Right arrow Articles by Romagnolo, D. F.
[Cancer Research 66, 2224-2232, February 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen

Jennifer K. Hockings1,2, Patricia A. Thorne3, Michael Q. Kemp2, Sherif S. Morgan1,2, Ornella Selmin3 and Donato F. Romagnolo1,2,4

1 Cancer Biology Interdisciplinary Graduate Program; 2 Laboratory of Mammary Gland Biology, Department of Nutritional Sciences; 3 Veterinary Sciences and Microbiology; and 4 Southwest Environmental Health Sciences Center, University of Arizona, Tucson, Arizona

Requests for reprints: Donato F. Romagnolo, Laboratory of Mammary Gland Biology, Department of Nutritional Sciences, 1177 East 4th Street, 303 Shantz Building, The University of Arizona, Tucson, AZ 85721-0038. Phone: 520-626-9108; Fax: 520-621-9446; E-mail: donato{at}u.arizona.edu.

In sporadic breast cancers, BRCA-1 expression is down-regulated in the absence of mutations in the BRCA-1 gene. This suggests that disruption of BRCA-1 expression may contribute to the onset of mammary tumors. Environmental contaminants found in industrial pollution, tobacco smoke, and cooked foods include benzo(a)pyrene [B(a)P] and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which have been shown to act as endocrine disruptors and tumor promoters. In previous studies, we documented that estrogen (E2) induced BRCA-1 transcription through the recruitment of an activator protein-1/estrogen receptor-{alpha} (ER{alpha}) complex to the proximal BRCA-1 promoter. Here, we report that activation of BRCA-1 transcription by E2 requires occupancy of the BRCA-1 promoter by the unliganded aromatic hydrocarbon receptor (AhR). The stimulatory effects of E2 on BRCA-1 transcription are counteracted by (a) cotreatment with the AhR antagonist 3'-methoxy-4'-nitroflavone; (b) transient expression in ER{alpha}-negative HeLa cells of ER{alpha} lacking the protein-binding domain for the AhR; and (c) mutation of two consensus xenobiotic-responsive elements (XRE, 5'-GCGTG-3') located upstream of the ER{alpha}-binding region. These results suggest that the physical interaction between the unliganded AhR and the liganded ER{alpha} plays a positive role in E2-dependent activation of BRCA-1 transcription. Conversely, we show that the AhR ligands B(a)P and TCDD abrogate E2-induced BRCA-1 promoter activity. The repressive effects of TCDD are paralleled by increased recruitment of the liganded AhR and HDAC1, reduced occupancy by p300, SRC-1, and diminished acetylation of H4 at the BRCA-1 promoter region flanking the XREs. We propose that the ligand status of the AhR modulates activation of the BRCA-1 promoter by estrogen. (Cancer Res 2006; 66(4): 2224-32)




This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
E. Swedenborg, J. Ruegg, S. Makela, and I. Pongratz
Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders
J. Mol. Endocrinol., July 1, 2009; 43(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. I. Karchner, M. J. Jenny, A. M. Tarrant, B. R. Evans, H. J. Kang, I. Bae, D. H. Sherr, and M. E. Hahn
The Active Form of Human Aryl Hydrocarbon Receptor (AHR) Repressor Lacks Exon 8, and Its Pro185 and Ala185 Variants Repress both AHR and Hypoxia-Inducible Factor
Mol. Cell. Biol., July 1, 2009; 29(13): 3465 - 3477.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. J. Gorski, R. D. Kennedy, A. M. Hosey, and D. P. Harkin
The Complex Relationship between BRCA1 and ER{alpha} in Hereditary Breast Cancer
Clin. Cancer Res., March 1, 2009; 15(5): 1514 - 1518.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. C. Degner, A. J. Papoutsis, O. Selmin, and D. F. Romagnolo
Targeting of Aryl Hydrocarbon Receptor-Mediated Activation of Cyclooxygenase-2 Expression by the Indole-3-Carbinol Metabolite 3,3'-Diindolylmethane in Breast Cancer Cells
J. Nutr., January 1, 2009; 139(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Singhal, K. Shankar, T. M. Badger, and M. J. Ronis
Estrogenic status modulates aryl hydrocarbon receptor--mediated hepatic gene expression and carcinogenicity
Carcinogenesis, February 1, 2008; 29(2): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.M. Coutts, N. Fulton, and R.A. Anderson
Environmental toxicant-induced germ cell apoptosis in the human fetal testis
Hum. Reprod., November 1, 2007; 22(11): 2912 - 2918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.